SCHEMBL10359666

SCHEMBL10359666

Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@@H](O)[C@@H](O)[C@@H](O)COP(=O)(O)O[C@H](Cn3c4nc(=O)[nH]c(=O)c-4nc4cc(C)c(C)cc43)[C@@H](O)[C@@H](O)CO)c2cc1C

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.76
▸ NR3C1 P04150 1/20 0.76
▸ ADRB2 P07550 1/20 0.76
▸ HTR2C P28335 1/20 0.76
▸ ADRA1A P35348 1/20 0.76
▸ PTGS2 P35354 1/20 0.76
▸ MEN1 O00255 7/20 0.73
▸ KMT2A Q03164 7/20 0.73
▸ USP2 O75604 4/20 0.73
▸ HTT P42858 4/20 0.73
▸ HAT1 O14929 4/20 0.73
▸ RBBP7 Q16576 4/20 0.73
▸ KDM4E B2RXH2 3/20 0.73
▸ RECQL P46063 3/20 0.73
▸ MAPT P10636 3/20 0.73
▸ CASP1 P29466 2/20 0.73
▸ BRCA1 P38398 2/20 0.73
▸ CASP7 P55210 2/20 0.73
▸ HSD17B10 Q99714 2/20 0.73
▸ TST Q16762 2/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Riboflavin 5'-Phosphate SCHEMBL29592831 0.90 ESR1 (0.93) ESR1NR3C1ADRB2HTR2CADRA1A
Riboflavin SCHEMBL396359 0.90 MEN1 (0.72) ESR1NR3C1ADRB2HTR2CADRA1A
SCHEMBL50097 0.88 MEN1 (0.74) ESR1NR3C1ADRB2HTR2CADRA1A
SCHEMBL6369069 0.88 MEN1 (0.73) ESR1NR3C1ADRB2HTR2CADRA1A
Riboflavin SCHEMBL50096 0.87 MEN1 (0.92) ESR1NR3C1ADRB2HTR2CADRA1A
Riboflavin SCHEMBL22034360 0.87 MEN1 (0.92) ESR1NR3C1ADRB2HTR2CADRA1A
Riboflavin SCHEMBL826819 0.87 MEN1 (0.92) ESR1NR3C1ADRB2HTR2CADRA1A
SCHEMBL478371 0.87 MEN1 (0.67) ESR1NR3C1ADRB2HTR2CADRA1A
SCHEMBL3402467 0.87 ESR1 (0.86) ESR1NR3C1ADRB2HTR2CADRA1A
Water SCHEMBL2005233 0.87 MEN1 (0.72) ESR1NR3C1ADRB2HTR2CADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2830627-B1 OCULAR TREATMENT SOLUTIONS, DELIVERY DEVICES AND DELIVERY AUGMENTATION METHODS EPION THERAPEUTICS INC (US) 2024-05-01 — — EP claimed
EP-0274189-B1 RIBOFLAVIN/FLUORESCENT LIGHT-INITIATED POLYMERIZATION OF WATER-SOLUBLE MONOMERS CALGON CORPORATION (US) 1990-12-27 — — EP claimed
Send feedback